StockVS

NASDAQ · USD

Cardio Diagnostics Holdings, Inc. (CDIOW) Stock Analysis

Cardio Diagnostics Holdings, Inc. (CDIOW) is a stock listed on NASDAQ and quoted in US Dollar.

CDIOW

$0.02

+$0.00 (+9.72%)

Sep 4, 2026 · Market close

This is a derivative instrument — a warrant on Cardio Diagnostics Holdings, Inc. (CDIO) common stock.

Issuer fundamentals are shown on the issuer page, not here.

View CDIO →

Price History

Hover for the daily close. The dotted line marks the period open.

CDIOW Key Statistics

As of Sep 4, 2026
Trading
Open
$0.02
Previous Close
$0.01
Day's Range
0.01–0.02
52-Week Range
0.01–0.02
Volume
18.13K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.23

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

CDIOW Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−21.00%
2025 (partial year)+0.00%

As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

About Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Visit website →